Merck's treatment for urinary, abdominal infections gets FDA approval

Επιχειρήσεις

17 Ιουλίου 2019

The U.S. Food and Drug Administration has approved Merck & Co Inc's combination treatment for complicated forms of urinary tract and abdominal infections, the drugmaker said on Wednesday.

Δείτε περισσότερα: Reuters.com

ΙΑΝΟΥΑΡΙΟΣ - ΜΑΡΤΙΟΣ 2016

ΤΕΥΧΟΣ

43

Α. Τσίπρας, Κ. Μητσοτάκης, EITO, Cisco, Accenture, PwC, IDC, WEF, Focus Bari

ΗΜΕΡΟΛΟΓΙΟ ΕΚΔΗΛΩΣΕΩΝ